PS-004 Analysis of the use of psychotropic drugs and pharmacological interactions in spanish chronic psychiatric patients
BackgroundSide effects produced by drugs are an emergent problem in developed countries, with major consequences for health assistance and economy. Polymedication produces important interactions which sometimes have relevant clinical repercussions.PurposeThe aim of this present study was to describe...
Gespeichert in:
Veröffentlicht in: | European journal of hospital pharmacy. Science and practice 2016-03, Vol.23 (Suppl 1), p.A216-A216 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A216 |
---|---|
container_issue | Suppl 1 |
container_start_page | A216 |
container_title | European journal of hospital pharmacy. Science and practice |
container_volume | 23 |
creator | Fernández-Ferreiro, A Martinez-Bahamonde, F Lopez-Lopez, A Pazos-Simon, N Guemas, E Paris, M Echarri-Arrieta, E Gonzalez-Barcia, M Suarez-Artime, P Lamas, M |
description | BackgroundSide effects produced by drugs are an emergent problem in developed countries, with major consequences for health assistance and economy. Polymedication produces important interactions which sometimes have relevant clinical repercussions.PurposeThe aim of this present study was to describe the current use of antipsychotic drugs in chronic patients in a psychiatric hospital and the potential risk of producing drug interactions (DI).Material and methodsThis was a descriptive cross sectional study analysing psychopharmacological therapeutics in patients admitted to a psychiatric hospital of 300 beds. For each patient, we obtained the following data: psychiatric disease, gender and age. Concerning pharmacotherapy, we obtained the following information: total number of drugs and type of oral or depot injection of antipsychotic medicines. Afterwards the major DI were listed using Micromedex Solutions.ResultsAmong 300 hospitalised patients who were studied, the majority were men (62%) with a median age of 49 ± 13 years; median age of women was 56 ± 16 years. The psychiatric diseases most frequently encountered were paranoid schizophrenia (34%) and undifferentiated schizophrenia (10%). 72% of patients were receiving more than 5 different medicines and the most prescribed being psychoactive drugs (62%). 94% of patients took antipsychotics, and among them, 27% as monotherapy. The average number of prescriptions of antipsychotic drugs per patient was 2.15, the most used being the atypical (70%) with olanzapine (20%), quetiapine (17%) and clozapine (13%). For typical antipsychotic drugs, we can highlight the use of levomepronazine (13%) and haloperidol (12%). 32% of patients (n = 95) were treated by depot injection of antipsychotic and the most frequently used were fluphenazine (34%), paliperidone (29%) and risperidone (28%). 68% of patients presented at least one major DI which increased the risk of developing side effects, with an average of 2 interactions per patient. The possible consequences of those DI were mostly increasing risk of a prolonged QT interval (59.4%) and an increasing risk of cardiac-respiratory arrest (8.3%).ConclusionPsychiatric patients receive a high number of medicines which interact, increasing the risk of occurrence of serious side effects. Detection of DI and therapy optimisation would reduce the risks associated with medication.No conflict of interest. |
doi_str_mv | 10.1136/ejhpharm-2016-000875.489 |
format | Article |
fullrecord | <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2552750594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2552750594</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1004-bf7f20eadafb64a842f532e561fd017e49323540897c36c7266b315349b379e53</originalsourceid><addsrcrecordid>eNp9kbtOwzAUhiMEEhX0HSwxp_jueKwqblIlkIDZchyncZXGwU6GioWFF-VJcFpgZDr_kf5z_bIMILhAiPBru236RoddjiHiOYSwEGxBC3mSzTCkIpeS09M_zfh5No_RlZARUkhK5Cx7f3pOdfTr43PZ6XYfXQS-BkNjwRjtJPu4N40fgu-dAVUYNxHorgKHsdr41m-c0S1w3WCDNoPzXUwJiL3uXGyAaYLvUuWhjdNDmLQenO2GeJmd1bqNdv4TL7LX25uX1X2-frx7WC3XeYnSanlZixpDqytdl5zqguKaEWwZR3UFkbBUEkwYhYUUhnAjMOclQYxQWRIhLSMX2dWxbx_822jjoLZ-DOncqDBjWDDI0jP-cSFRUMYhgiK5yNFV7raqD26nw14hqCYc6heHmnCoIw6VcJBvY96BFQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784560107</pqid></control><display><type>article</type><title>PS-004 Analysis of the use of psychotropic drugs and pharmacological interactions in spanish chronic psychiatric patients</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Fernández-Ferreiro, A ; Martinez-Bahamonde, F ; Lopez-Lopez, A ; Pazos-Simon, N ; Guemas, E ; Paris, M ; Echarri-Arrieta, E ; Gonzalez-Barcia, M ; Suarez-Artime, P ; Lamas, M</creator><creatorcontrib>Fernández-Ferreiro, A ; Martinez-Bahamonde, F ; Lopez-Lopez, A ; Pazos-Simon, N ; Guemas, E ; Paris, M ; Echarri-Arrieta, E ; Gonzalez-Barcia, M ; Suarez-Artime, P ; Lamas, M</creatorcontrib><description>BackgroundSide effects produced by drugs are an emergent problem in developed countries, with major consequences for health assistance and economy. Polymedication produces important interactions which sometimes have relevant clinical repercussions.PurposeThe aim of this present study was to describe the current use of antipsychotic drugs in chronic patients in a psychiatric hospital and the potential risk of producing drug interactions (DI).Material and methodsThis was a descriptive cross sectional study analysing psychopharmacological therapeutics in patients admitted to a psychiatric hospital of 300 beds. For each patient, we obtained the following data: psychiatric disease, gender and age. Concerning pharmacotherapy, we obtained the following information: total number of drugs and type of oral or depot injection of antipsychotic medicines. Afterwards the major DI were listed using Micromedex Solutions.ResultsAmong 300 hospitalised patients who were studied, the majority were men (62%) with a median age of 49 ± 13 years; median age of women was 56 ± 16 years. The psychiatric diseases most frequently encountered were paranoid schizophrenia (34%) and undifferentiated schizophrenia (10%). 72% of patients were receiving more than 5 different medicines and the most prescribed being psychoactive drugs (62%). 94% of patients took antipsychotics, and among them, 27% as monotherapy. The average number of prescriptions of antipsychotic drugs per patient was 2.15, the most used being the atypical (70%) with olanzapine (20%), quetiapine (17%) and clozapine (13%). For typical antipsychotic drugs, we can highlight the use of levomepronazine (13%) and haloperidol (12%). 32% of patients (n = 95) were treated by depot injection of antipsychotic and the most frequently used were fluphenazine (34%), paliperidone (29%) and risperidone (28%). 68% of patients presented at least one major DI which increased the risk of developing side effects, with an average of 2 interactions per patient. The possible consequences of those DI were mostly increasing risk of a prolonged QT interval (59.4%) and an increasing risk of cardiac-respiratory arrest (8.3%).ConclusionPsychiatric patients receive a high number of medicines which interact, increasing the risk of occurrence of serious side effects. Detection of DI and therapy optimisation would reduce the risks associated with medication.No conflict of interest.</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2016-000875.489</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Antipsychotics ; Drug therapy ; Patients ; Psychotropic drugs ; Schizophrenia</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A216-A216</ispartof><rights>2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>2016 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids></links><search><creatorcontrib>Fernández-Ferreiro, A</creatorcontrib><creatorcontrib>Martinez-Bahamonde, F</creatorcontrib><creatorcontrib>Lopez-Lopez, A</creatorcontrib><creatorcontrib>Pazos-Simon, N</creatorcontrib><creatorcontrib>Guemas, E</creatorcontrib><creatorcontrib>Paris, M</creatorcontrib><creatorcontrib>Echarri-Arrieta, E</creatorcontrib><creatorcontrib>Gonzalez-Barcia, M</creatorcontrib><creatorcontrib>Suarez-Artime, P</creatorcontrib><creatorcontrib>Lamas, M</creatorcontrib><title>PS-004 Analysis of the use of psychotropic drugs and pharmacological interactions in spanish chronic psychiatric patients</title><title>European journal of hospital pharmacy. Science and practice</title><description>BackgroundSide effects produced by drugs are an emergent problem in developed countries, with major consequences for health assistance and economy. Polymedication produces important interactions which sometimes have relevant clinical repercussions.PurposeThe aim of this present study was to describe the current use of antipsychotic drugs in chronic patients in a psychiatric hospital and the potential risk of producing drug interactions (DI).Material and methodsThis was a descriptive cross sectional study analysing psychopharmacological therapeutics in patients admitted to a psychiatric hospital of 300 beds. For each patient, we obtained the following data: psychiatric disease, gender and age. Concerning pharmacotherapy, we obtained the following information: total number of drugs and type of oral or depot injection of antipsychotic medicines. Afterwards the major DI were listed using Micromedex Solutions.ResultsAmong 300 hospitalised patients who were studied, the majority were men (62%) with a median age of 49 ± 13 years; median age of women was 56 ± 16 years. The psychiatric diseases most frequently encountered were paranoid schizophrenia (34%) and undifferentiated schizophrenia (10%). 72% of patients were receiving more than 5 different medicines and the most prescribed being psychoactive drugs (62%). 94% of patients took antipsychotics, and among them, 27% as monotherapy. The average number of prescriptions of antipsychotic drugs per patient was 2.15, the most used being the atypical (70%) with olanzapine (20%), quetiapine (17%) and clozapine (13%). For typical antipsychotic drugs, we can highlight the use of levomepronazine (13%) and haloperidol (12%). 32% of patients (n = 95) were treated by depot injection of antipsychotic and the most frequently used were fluphenazine (34%), paliperidone (29%) and risperidone (28%). 68% of patients presented at least one major DI which increased the risk of developing side effects, with an average of 2 interactions per patient. The possible consequences of those DI were mostly increasing risk of a prolonged QT interval (59.4%) and an increasing risk of cardiac-respiratory arrest (8.3%).ConclusionPsychiatric patients receive a high number of medicines which interact, increasing the risk of occurrence of serious side effects. Detection of DI and therapy optimisation would reduce the risks associated with medication.No conflict of interest.</description><subject>Antipsychotics</subject><subject>Drug therapy</subject><subject>Patients</subject><subject>Psychotropic drugs</subject><subject>Schizophrenia</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kbtOwzAUhiMEEhX0HSwxp_jueKwqblIlkIDZchyncZXGwU6GioWFF-VJcFpgZDr_kf5z_bIMILhAiPBru236RoddjiHiOYSwEGxBC3mSzTCkIpeS09M_zfh5No_RlZARUkhK5Cx7f3pOdfTr43PZ6XYfXQS-BkNjwRjtJPu4N40fgu-dAVUYNxHorgKHsdr41m-c0S1w3WCDNoPzXUwJiL3uXGyAaYLvUuWhjdNDmLQenO2GeJmd1bqNdv4TL7LX25uX1X2-frx7WC3XeYnSanlZixpDqytdl5zqguKaEWwZR3UFkbBUEkwYhYUUhnAjMOclQYxQWRIhLSMX2dWxbx_822jjoLZ-DOncqDBjWDDI0jP-cSFRUMYhgiK5yNFV7raqD26nw14hqCYc6heHmnCoIw6VcJBvY96BFQ</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Fernández-Ferreiro, A</creator><creator>Martinez-Bahamonde, F</creator><creator>Lopez-Lopez, A</creator><creator>Pazos-Simon, N</creator><creator>Guemas, E</creator><creator>Paris, M</creator><creator>Echarri-Arrieta, E</creator><creator>Gonzalez-Barcia, M</creator><creator>Suarez-Artime, P</creator><creator>Lamas, M</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201603</creationdate><title>PS-004 Analysis of the use of psychotropic drugs and pharmacological interactions in spanish chronic psychiatric patients</title><author>Fernández-Ferreiro, A ; Martinez-Bahamonde, F ; Lopez-Lopez, A ; Pazos-Simon, N ; Guemas, E ; Paris, M ; Echarri-Arrieta, E ; Gonzalez-Barcia, M ; Suarez-Artime, P ; Lamas, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1004-bf7f20eadafb64a842f532e561fd017e49323540897c36c7266b315349b379e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antipsychotics</topic><topic>Drug therapy</topic><topic>Patients</topic><topic>Psychotropic drugs</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fernández-Ferreiro, A</creatorcontrib><creatorcontrib>Martinez-Bahamonde, F</creatorcontrib><creatorcontrib>Lopez-Lopez, A</creatorcontrib><creatorcontrib>Pazos-Simon, N</creatorcontrib><creatorcontrib>Guemas, E</creatorcontrib><creatorcontrib>Paris, M</creatorcontrib><creatorcontrib>Echarri-Arrieta, E</creatorcontrib><creatorcontrib>Gonzalez-Barcia, M</creatorcontrib><creatorcontrib>Suarez-Artime, P</creatorcontrib><creatorcontrib>Lamas, M</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fernández-Ferreiro, A</au><au>Martinez-Bahamonde, F</au><au>Lopez-Lopez, A</au><au>Pazos-Simon, N</au><au>Guemas, E</au><au>Paris, M</au><au>Echarri-Arrieta, E</au><au>Gonzalez-Barcia, M</au><au>Suarez-Artime, P</au><au>Lamas, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PS-004 Analysis of the use of psychotropic drugs and pharmacological interactions in spanish chronic psychiatric patients</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><date>2016-03</date><risdate>2016</risdate><volume>23</volume><issue>Suppl 1</issue><spage>A216</spage><epage>A216</epage><pages>A216-A216</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>BackgroundSide effects produced by drugs are an emergent problem in developed countries, with major consequences for health assistance and economy. Polymedication produces important interactions which sometimes have relevant clinical repercussions.PurposeThe aim of this present study was to describe the current use of antipsychotic drugs in chronic patients in a psychiatric hospital and the potential risk of producing drug interactions (DI).Material and methodsThis was a descriptive cross sectional study analysing psychopharmacological therapeutics in patients admitted to a psychiatric hospital of 300 beds. For each patient, we obtained the following data: psychiatric disease, gender and age. Concerning pharmacotherapy, we obtained the following information: total number of drugs and type of oral or depot injection of antipsychotic medicines. Afterwards the major DI were listed using Micromedex Solutions.ResultsAmong 300 hospitalised patients who were studied, the majority were men (62%) with a median age of 49 ± 13 years; median age of women was 56 ± 16 years. The psychiatric diseases most frequently encountered were paranoid schizophrenia (34%) and undifferentiated schizophrenia (10%). 72% of patients were receiving more than 5 different medicines and the most prescribed being psychoactive drugs (62%). 94% of patients took antipsychotics, and among them, 27% as monotherapy. The average number of prescriptions of antipsychotic drugs per patient was 2.15, the most used being the atypical (70%) with olanzapine (20%), quetiapine (17%) and clozapine (13%). For typical antipsychotic drugs, we can highlight the use of levomepronazine (13%) and haloperidol (12%). 32% of patients (n = 95) were treated by depot injection of antipsychotic and the most frequently used were fluphenazine (34%), paliperidone (29%) and risperidone (28%). 68% of patients presented at least one major DI which increased the risk of developing side effects, with an average of 2 interactions per patient. The possible consequences of those DI were mostly increasing risk of a prolonged QT interval (59.4%) and an increasing risk of cardiac-respiratory arrest (8.3%).ConclusionPsychiatric patients receive a high number of medicines which interact, increasing the risk of occurrence of serious side effects. Detection of DI and therapy optimisation would reduce the risks associated with medication.No conflict of interest.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/ejhpharm-2016-000875.489</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2047-9956 |
ispartof | European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A216-A216 |
issn | 2047-9956 2047-9964 |
language | eng |
recordid | cdi_proquest_journals_2552750594 |
source | PubMed Central; EZB Electronic Journals Library |
subjects | Antipsychotics Drug therapy Patients Psychotropic drugs Schizophrenia |
title | PS-004 Analysis of the use of psychotropic drugs and pharmacological interactions in spanish chronic psychiatric patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T19%3A51%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PS-004%E2%80%85Analysis%20of%20the%20use%20of%20psychotropic%20drugs%20and%20pharmacological%20interactions%20in%20spanish%20chronic%20psychiatric%20patients&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=Fern%C3%A1ndez-Ferreiro,%20A&rft.date=2016-03&rft.volume=23&rft.issue=Suppl%201&rft.spage=A216&rft.epage=A216&rft.pages=A216-A216&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2016-000875.489&rft_dat=%3Cproquest_bmj_p%3E2552750594%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1784560107&rft_id=info:pmid/&rfr_iscdi=true |